Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men

Journal of Hypertension

Volumn 16, Issue 10, 1998, Pages 1475-1480

  Schorr, Ulrike ^a   Blaschke, Klaus ^a   Turan, Selma ^a   Distler, Armin ^a   Sharma, Arya M ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Angiotensinogen; Blood pressure; Family history of hypertension; Leptin; Normotensives; Oral glucose tolerance

Indexed keywords

ANGIOTENSINOGEN; ELECTROLYTE; GLUCOSE; INSULIN; LEPTIN; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROLYTE BLOOD LEVEL; FAMILY HISTORY; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

EID: 0031714508     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816100-00011     Document Type: Article

References (36)

1. Joint National Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 24:2413-2446.
2. Weigle DS. Leptin and other secretory products of adipocytes modulate multiple physiological functions. Ann Endocrinol Paris 1997; 58: 132-136.
3. Beige J, Engeli S, Distler A, Sharma AM. Angiotensinogen-gene expression in human adipose tissue. J Hypertens 1996; 14 (suppl 1):S28.
4. Jones BH, Standridge MK, Taylor JW, Moustaid N. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol 1997; 273:R236-R242.
5. Frederich RCJ, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992; 19:339-344.
6. Sharma AM. Salt sensitivity as a phenotype for genetic studies of human hypertension. Nephrol Dial Transplant 1996; 11:927-929.
7. Fasola AF, Martz BL, Helmer OM. Renin activity during supine exercise in normotensives and hypertensives. J Appl Physiol 1966; 21: 1709-1712.
8. Watt GC, Harrap SB, Foy CJ, Holton DW, Edwards HV, Davidson HR, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992; 10:473-482.
9. Sinha MK. Human leptin: the hormone of adipose tissue. Eur J Endocrinol 1997; 136:461-464.
10. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45:988-991.
11. Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y, et al. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10:1171-1174.
12. Blümel A, Oelkers W. Measurement of human plasma renin substrate concentration by angiotensin I radioimmunoassay: a discussion of methodical problems. Z Klin Chem Klin Biochem 1974; 12:453-458.
13. Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-1197.
14. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
15. Lönnqvist F, Nordfors L, Jansson M, Thörne A, Schalling M, Arner P. Leptin secretion from adipose tissue in women: relationship to plasma levels and gene expression. J Clin Invest 1997; 99:2398-2404.
16. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95:948-953.
17. Cooper R, Forrester T, Ogunbiyi O, Muffinda J. Angiotensinogen levels and obesity in four black populations. J Hypertens 1998; 16:571-575.
18. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997; 10:629-633.
19. Murakami E, Hiwada K, Kokubu T. Effects of insulin and glucagon on production of renin substrate by the isolated rat liver. J Endocrinol 1980; 85:151-153.
20. Misbin RI, Grant MB, Pecker MS, Atlas SA. Elevated levels of plasma prorenin (inactive renin) in diabetic and nondiabetic patients with autonomic dysfunction. J Clin Endocrinol Metab 1987; 64:964-968
21. Ferriss JB, O'Hare JA, Kelleher CC, Sullivan PA, Cole MM, Ross HF, et al. Diabetic control and the renin-angiotensin system, catecholamines, and blood pressure. Hypertension 1985; 7 (suppl II):II58-II63.
22. Walker WG, Whelton PK, Saito H, Russell RP, Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1:287-291.
23. Ménard J, el Amrani AI, Savoie F, Bouhnik J. Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension 1991; 18:705-707.
24. Gardes J, Bouhnik J, Clauser E, Corvol P, Ménard J. Role of angiotensinogen in blood pressure homeostasis. Hypertension 1982; 4:185-189.
25. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
26. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235T-variant and essential hypertension in Caucasians: a systematic review and methodological appraisal. Hypertension 1997; 30:1331-1337.
27. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-1797.
28. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 1996; 380:677.
29. De Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, et al. Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 1997; 14:200-208.
30. Muscelli E, Camastra S, Masoni A, Baldi S, Sironi AM, Natali A, et al. Acute insulin administration does not affect plasma leptin levels in lean or obese subjects. Eur J Clin Invest 1996; 26:940-943.
31. Clapham JC, Smith SA, Moore GBT, Hughes MG, Azam H, Scott A, et al. Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans. Int J Obes 1997; 21:179-183.
32. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y, et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 1991; 91:589-596.
33. Sharma AM, Ruland K, Spies KP, Distler A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 1991; 9:329-335.
34. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997; 82:1293-1300.
35. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997; 95:2348-2350.
36. Weir RJ, Briggs E, Mack A, Naismith L, Taylor L, Wilson E. Blood pressure in women taking oral contraceptives. BMJ 1974; 1:533-535.